About us- new updates
A Game Changer in
We are a team of passionate life sciences, cybersecurity and digital innovation experts that work to bring a transition to the future of drug and medical decice development, with online solutions that can reduce the cost and time of taking a new medical product through clinical trials.
Trough the in silico technology, we can increase the quality of life of millions of patients by allowing accessible treatments, bringing innovative drugs to the market faster, together with personalized cures and new solutions for rare diseases.
The future of medicine lies in personalized treatments tailored to individual patient characteristics. With our computational modeling and simulation platform, we aim to enable this healthcare revolution through user-friendly and integrated in silico nonclinical and clinical solutions.
We are ready for the future of medicine, are you?
Revolutionize drug and medical-device development by harnessing the power of in silico technology
Boost the world’s transition to accessible therapies
Meet the Team
Sr. Product Manager MedTech
MARC ANTONIO BISOTTI
Co-Founder & Exec. VP of R&D
Sr. Product Manager MedTech
Digital Marketing Specialist
Founder and CEO
Business Development Manager
Head of PR & Communication
VP of Sales & Marketing
We are actively involved with the third SDG – Good Health and Well-being (Ensure healthy lives and promote well-being for all at all ages) with a specific focus on target 3.B – support research, development, and universal access to affordable vaccines and medicines. Our technology allows for significant cost and time savings in drug development, which results in faster-to- market medicines and medical devices.
Another goal we actively tackle is SDG 9 – Industry, Innovation, and Infrastructure (Build resilient infrastructure, promote inclusive and sustainable industrialization, and foster innovation) with a specific focus on target 9.5 – enhance research and upgrade industrial technologies.
With our platform, we want to make in silico trials more accessible to all Pharma and medical devices companies – even to SMEs and emerging BioTechs that usually don’t have the same competitive budget as established Big Pharma to perform clinical trials.
We are also committed to a long-term goal: the reduction and replacement of animals in research since in silico trials can be used as substitutes for in vivo testing.
Diversity & Inclusion
InSilicoTrials is an Equal Opportunity Employer. All our employees have been and will be selected without regard to race, color, age, religion, sex, sexual orientation, gender identity /expression and national origin. As a company with 16 employees representing 6 different nationalities, InSilicoTrials is committed to foster and deliver innovation through a diverse workforce and a fast-paced inclusive environment.
Gender diversity is central to our inclusion policies. In fact, gender representation criteria are integrated into our hiring metrics allowing 50% of female employees within our team with equal and competitive remuneration plans.